Elzonris 1000 ug/mL
tagraxofusp · INJECTION, SOLUTION · Stemline Therapeutics, Inc.
No Recall History
Plain English
Elzonris is a injection, solution containing tagraxofusp at 1000 ug/mL, taken intravenous. Manufactured by Stemline Therapeutics, Inc..
Key Facts
- Brand Name
- Elzonris
- Generic Name
- tagraxofusp
- NDC Code (Product)
72187-0401- Manufacturer
- Stemline Therapeutics, Inc.
- Strength
- 1000 ug/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761116
- Drug Class
- CD123 Interaction [EPC]; Cytotoxin [EPC]
- Marketing Start
- 01/18/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Elzonris used for?
Elzonris contains tagraxofusp. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Elzonris a controlled substance?
Elzonris is not classified as a controlled substance by the DEA.
What is the generic name for Elzonris?
The generic name for Elzonris is tagraxofusp. There are no other listed brand versions of tagraxofusp.
What is the NDC code for Elzonris 1000 ug/mL?
The NDC (National Drug Code) for Elzonris 1000 ug/mL is 72187-0401, listed by Stemline Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)